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Abstract:  Hepatitis B virus (HBV) genomes are small, semi-double-stranded DNA 
circular genomes that contain alternating overlapping reading frames and replicate through 
an RNA intermediary phase. This complex biology has presented a challenge to estimating 
an evolutionary rate for HBV, leading to difficulties resolving the evolutionary and 
epidemiological history of the virus. Here, we re-examine rates of HBV evolution using a 
novel data set of 112 within-host, transmission history (pedigree) and among-host genomes 
isolated over 20 years from the indigenous peoples of the South Pacific, combined   
with 313 previously published HBV genomes. We employ Bayesian phylogenetic 
approaches to examine several potential causes and consequences of evolutionary rate 
variation in HBV. Our results reveal rate variation both between genotypes and across the 
genome, as well as strikingly slower rates when genomes are sampled in the Hepatitis B e 
antigen positive state, compared to the e antigen negative state. This Hepatitis B e antigen 
rate variation was found to be largely attributable to changes during the course of infection 
in the preCore and Core genes and their regulatory elements.  
Keywords: hepatitis B virus; molecular clock; Bayesian phylogenetics 
 
1. Introduction 
Recent methodological advances in the genetic analysis of measurably evolving populations   
(MEPs [1]) have lead to the development of a wide range of models to investigate the underlying 
biological processes of viral evolution [2,3]. For example, it has become routine to use the temporal 
information, such as time of sampling, in genealogical analyses of viral data. These data provide a way 
to calibrate the rate of molecular evolution to calendar time, making it possible to test hypotheses 
about the timing and nature of specific evolutionary and epidemiological events. If the evolutionary 
rate is known, it is possible to estimate, for example, when a pathogen was first introduced into   
a particular species or population (e.g., [4]), to characterize variation in the rate of molecular   
evolution between viral subpopulations (e.g., [5]), or to reconstruct the demographic history of   
an epidemic (e.g., [6]). 
For many viral data sets, the rate at which mutations accumulate is fast relative to the temporal 
period over which samples are isolated. The genetic diversity that accumulates over that time period 
can be used to inform estimates of the rate [1]. This is particularly true for RNA viruses, whose rapid 
rate of evolution makes them ideally suited for such analyses [7,8]. DNA viruses, alternatively, are 
thought to evolve more slowly, and consequently may be less suitable for evolutionary analyses 
spanning short time-frames (but see [9,10]).  
Although Hepatitis B Virus (HBV) is classified as a DNA virus, it replicates through an RNA 
intermediary phase. HBV encodes its own reverse transcriptase, which, like those of rapidly evolving Viruses 2011, 3                  
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retroviruses, lacks proofreading capability, providing HBV the potential for high mutation rates. 
Nonetheless, previous research to quantify the tempo of HBV evolution have estimated rates at the 
lower range of RNA virus rates: around 1.4  10
−4–5.7  10
−5 substitutions per site per year [11–18]. 
While these rates are relatively slow, they are simultaneously too fast to reflect the suggested 
long-term association, and possibly co-speciation, between HBV strains and their primate hosts [19] 
and too slow to explain its extensive global genetic diversity [11–18].  
The lack of resolution regarding HBV evolutionary rates is likely attributable to its complex 
biology. The HBV genome is highly constrained due to its small size (3200 base-pairs; bp), extensive 
overlapping reading frames and RNA secondary structure. These constraints result in high variability 
in substitution rates across the genome, for example, between the non-overlapping and overlapping 
coding regions. Nonetheless, the error-prone nature of its reverse transcriptase and frequent 
recombination at both the intra- and inter-genotype level [20] and between strains [21] can rapidly 
generate de novo diversity.  
Strong host-pathogen interactions may also influence estimated rates of evolution in HBV, for 
example the regulation and expression of the Hepatitis B e antigen (HBeAg) and the Hepatitis B Core 
antigen (HBcAg). During early chronic infection, the HBeAg is expressed and stimulates regulatory  
T CD4 cells that suppress anti-viral T CD8 cell responses against HBcAg, which is a key antigen 
expressed on the hepatocyte cell walls [22,23]. HBeAg expression therefore assists in viral persistence, 
and prevents excessive immunological damage to the liver. In late chronic infection, the host 
frequently develops antibodies to HBeAg and/or the virus mutates, resulting in HBeAg negative 
(HBeAg-ve) infection. The mutations that can induce the HBeAg-ve status are collectively referred to 
as ‘preCore mutations’. Some preCore mutations eliminate HBeAg expression while others only 
modify expression. The most common of these mutations is a G to A substitution at nucleotide 
position (np) 1896 (G1896A), which creates a stop codon aborting the translation of the HBeAg and 
strengthens the secondary folding structure of the encapsulation signal () on the viral RNA   
pre-genome, increasing viral replication [24–26]. The mutation also allows the host to mount an 
unregulated immune response against infected hepatocytes, typically leading to a lower viral load and 
less infectious state [18,27]. Indeed, observations that HBeAg-ve infections are frequently 
characterized by high nucleotide diversity compared to HBeAg+ve infections [12,16,18,28–30] may be 
explained by the increase in replication rate, combined with increase selection pressure in HBcAg. 
This situation would lead to variation in evolutionary rate during the course of infection, adding further 
complexity to rate estimation. 
Here, we investigate these potential causes of evolutionary rate variation in HBV using a novel data 
set of 360 complete HBV genomes, representing several distinct genotypes sampled across the global 
distribution of the viruses and nearly 30 years of HBV evolutionary history (Table 1). We utilize the 
flexible phylogenetic analysis framework in BEAST [31] to design analyses that (1) allow pooling of 
molecular data (including recombinant lineages) without requiring that all model parameters be shared 
among every sequence; and (2) model variation in evolutionary rate both within the genome and 
between certain subsets of the data (such as HBeAg-ve sequences). We explore the patterns of 
evolutionary rate variation both within and between HBV genotypes and to test hypotheses about the 
influence of evolutionary constraints and changes in HBeAg status on rates of HBV evolution. 
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Table 1. Details of the 15 data sets used in the analyses described in the main text. When more than one “subpopulation” is included in a data 
set, each informs its own genealogy using the shared-rate approach. 
   Data sets  Data set name  Genotypes Number of 
sequences HBeAg+ve HBeAg-ve  Recombinants 
strains  
Subpopulations  
per data set 
Serially sampled 
Within Host and 
Family 
Transmission 
sequences 
1  Within Host Genotype C  WH-C  C  11  9  2  0  4 
2  Within Host Genotype D  WH-D  D  27  21  6  0  13 
3  Within Host recombinant sequences of 
Genotypes B and C  WH-BC rBC  16  1  15  -  8 
4 
Family Transmission sequences of 
Genotype D and recombinant 
sequences of Genotypes B and C 
WH-Fa  D,  rBC  13  7 6 0  3 
5 
HBeAg+ve Within Host and Family 
Transmission sequences of Genotypes 
C, D and recombinant sequences of B 
and C 
WH-HBeAg+ve C, D, rBC  54  n/a  n/a  0  3 
6 
HBeAg-ve Within Host and Family 
Transmission sequences comprised of 
recombinant genotype B and C 
WH-HBeAg-ve rBC 34  n/a  n/a  0  9 
Among Host 
epidemiologically 
unrelated sequences
7  Among Host Genotype A  AH-A  A  37  37  0  5  n/a 
8  Among Host Genotype B  AH-B  B  15  5  10  -  n/a 
9  Among Host Genotype C  AH-C  C  63  18  18  -  n/a 
10 Among Host Genotype D  AH-D  D  56  25  25  -  n/a 
11 Among Host Genotype E  AH-E  E  49  45  45  0  n/a 
12 Among Host Genotype F  AH-F  F  35  26  26  4  n/a 
13 Among Host Genotype H  AH-H  H  22  22  22  0  n/a 
14 Among Host HBeAg+ve  AH-HBeAg+ve C, D  76  n/a  n/a  n/a  n/a 
15 Among Host HBeAg-ve  AH-HBeAg-ve C, D  43  n/a  n/a  n/a  n/a 
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2. Results and Discussion  
2.1. Variation in Evolutionary Rate between HBV Genotypes  
Table 2 shows the estimated evolutionary rates for each of the nine genotype-specific data sets (data 
sets 1–3, 7, 9–13; Table 1). For each data set, we estimated evolutionary rates using both a strict and a 
relaxed (uncorrelated lognormal distribution, ucld) molecular clock. For the relaxed clock analyses, 
two mean rates are given: the ucld mean (µ), which is the mean of the rates on all the branches, and the 
weighted-mean (µw), which is calculated by averaging the rates across all the branches in   
the genealogy, where each branch-specific rate is weighted according to the length (time) of each 
branch [32]. Relaxed clock results are not reported for the WH-C data set or for the WH-D HBeAg+ve 
data set as insufficient data were available to estimate a rate under this model. Further, no µw results 
were given for the WH-Fa data sets, as the shared-rate approach (defined below) provides a different 
µw for each family, as each family (subpopulation) informs its own, separate genealogy. 
Although the 95% highest posterior density (HPD) intervals are often wide, the evolutionary   
rate varies considerably among the different genotypes analyzed. Most of our genotype-specific   
rate estimates fall within the range of rates estimated previously for HBV genomes   
(1.4  10
−4–5.7  10
−5); [11–18]. The among-host rate for HBV-A is the fastest rate estimated, with the 
95% HPD intervals of both the strict and relaxed clock rates falling outside the previously published 
range. This is consistent with molecular assays that have shown a faster rate of replication for HBV-A 
compared to HBV-C and HBV-D [33]. In contrast to these results, Zehender et al. [34] reported rates 
estimated for the polymerase and surface antigen sequences of HBV genotypes A and D from a sample 
of patients in northwest Italy, in which they found a much faster rate for genotype D than for   
genotype A. The difference between this and our study may be due to the genomic region analyzed 
(our estimates are from complete genomes) or to population-specific differences in evolutionary rate.  
The observed variation in evolutionary rate between different HBV genotypes may be explained by 
differences in their underlying biological properties. Evolutionary rate is a function of mutation rate 
and generation time (and thus replication rate), as well as the impact of natural selection. While each 
genotype has the same genomic structure and encodes the same polymerase enzyme, which probably 
results in similar mutational potential, they each have different primary routes of transmission, 
duration of infection, serological profiles and replication rates. For example, because of their 
geographic associations with developing nations and hyperendemicity, genotypes A-1, B, C and E are 
more likely to infect young children and infants, whereas genotypes A-2 D, F and H are more likely to 
be transmitted among adults [35–38]. Consequently the duration of infection and the time between 
transmission events for genotypes A-1, B, C and E are usually longer than for other genotypes. 
However, given the limited data currently available for many genotypes (for example, only 11 years of 
temporal data are currently available for genotype E) and the resulting large credible intervals, a larger 
sample size will be necessary to confirm this observation. Further, future insights into the 
quantification of the replication processes, selection pressures from the host immune system, and 
evolutionary dynamics of the genotypes as well as specific strains may better explain the observed rate 
variation between genotypes. Viruses 2011, 3                  
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When genotype-specific data sets were analyzed assuming the lognormal relaxed clock model, µ 
was observed to be greater than µw for each data set that contained a significant proportion of 
HBeAg-ve genomes. This result indicates a non-random distribution of rate variation along the trees. 
Such a pattern may emerge when a larger proportion of evolutionary changes occur along branches 
with short evolutionary time. Analysis of the maximum clade credibility (MCC) trees, on which it is 
possible to visualize the distribution of branch-rates summarized across all posterior trees, suggested 
that, when both HBeAg-ve and HBeAg+ve sequences were included in an alignment, the faster 
evolutionary rates were observed predominantly along branches leading to HBeAg-ve leaves   
(Figure 1). The highest rates occur almost exclusively along the short, terminal branches leading   
to HBeAg-ve sequences, suggesting that these lineages are evolving more rapidly than   
HBeAg+ve sequences.  
Figure 1. Maximum clade credibility (MCC) resulting from the analysis of the Genotype 
D between-host data set. Colors along the branches indicate relative rates, from a scale of 
blue (the most slowly-evolving branches) to red (the most rapidly-evolving branches). 
Taxon labels of the most rapidly evolving branches are highlighted in red. 
 Viruses 2011, 3                  
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2.2. Variation in Evolutionary Rate by HBeAg Status  
To test whether HBeAg+ve genomes have slower average evolutionary rates than HBeAg-ve 
genomes, we performed additional analyses for the WH-D, AH-C, AH-D and AH-F data sets (data sets 
that contained both HBeAg+ve and -ve sequences) in which we excluded HBeAg-ve sequences   
(Table 3), thereby estimating a separate evolutionary rate only for HBeAg+ve sequences. Although 
confidence intervals sometimes overlapped, for each data set, the HBeAg+ve evolutionary rates were 
slower than those estimated from the full data sets. In addition, similar µ and µw rates were obtained 
when only HBeAg+ve sequences were analyzed.  
A change in status from HBVeAg+ve to HBVeAg-ve has been proposed previously to be associated 
with an increase in evolutionary rate [18]. To explore this further, we created four combined data sets 
according to HBeAg antigen status and whether the genomes were from WH (within host) or AH 
(among host) data sets (data sets 5, 6, 14 and 15; Table 1). We then estimated evolutionary rates under 
both a strict and relaxed clock model for each of these four data sets. For each analysis, we used the 
shared-rate approach so that each genotype informed its own separate genealogy while the other model 
parameters could be shared across the genotypes. For the relaxed clock analyses, all of the data in each 
data set were used to estimate the evolutionary rate. However, because each genotype has its own 
genealogy, the weighted mean evolutionary rate (µw) can differ by genealogy, thus µw is estimated 
separately for each subpopulation. For all four data sets, the standard deviations of the lognormal rate 
distributions in the relaxed clock analysis were skewed towards zero, indicating insufficient 
information to estimate rates under this model. However, in the strict clock analyses, although the 
HPD intervals overlap in the among-host data sets, the average rates estimated for both HBeAg+ve 
data sets were markedly slower than those of the corresponding HBeAg-ve data set (Table 4). This is 
most pronounced in the within-host data sets, which allow a direct comparison of the evolutionary 
rates of the same HBV infection before and after seroconversion from HBeAg+ve to HBeAg-ve. These 
results therefore add more weight to the hypothesis that evolutionary rate is affected by e-antigen status. 
Rate variation according to HBeAg status may also have contributed to the variation observed 
between genotypes. Because of genotype-specific nucleotide variations, genotype A and specific 
strains of C and F seroconvert less frequently, or at a later stage of infection, to HBeAg-ve status (via 
the G1896A mutation) and are more likely to experience CURS and BCP mutations (the CURS-Core 
region comprises the Core Upstream Regulatory String (CURS) and Basal Core Promoter (BCP) 
region, which regulate translation of the HBeAg, as well as the HBeAg and HBcAg coding region) 
than are genotypes B, D, E, and H (a factor that is attributed to their increased virulence) [36,39–41]. 
While the G1896A mutation eliminates HBeAg expression and enhances replication, mutations in the 
CURS and BCP only modify HBeAg expression and do not enhance replication significantly [26,33]. 
And finally, genotype A has a stronger encapsulation signal structure which significantly increases 
replication [24,26,33]. These sequence variations, which result in different HBeAg serological profiles, 
will also induce different selection pressures from the host immune system.  Viruses 2011, 3                  
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Table 2. Evolutionary rates estimated assuming the strict molecular clock and the uncorrelated lognormal (UCLD) relaxed clock. The 
difference between the mean rate and the weighted mean rate is explained in the main text. The WH-C HBeAg+ve data set contained 
insufficient information to estimate an evolutionary rate under the relaxed clock, and these results are not reported here. 
Data Set Antigen  state Strict  Clock  UCLD Relaxed Clock  UCLD Relaxed Clock 
    
Mean 95%  HPD 
UCLD 
Mean 
95% HPD 
Weighted 
Mean 
95% HPD 
AH-A HBeAg+ve  6.01E-04 4.07E-04–7.83E-04 8.60E-04 4.34E-04–1.43E-03  8.04E-04 4.41E-04–1.26E-03 
AH-C HBeAg+ve  and  -ve 1.23E-04 2.81E-05–2.12E-04 2.00E-04 5.41E-05–3.61E-04  1.88E-04 5.09E-05–3.34E-04 
AH-D HBeAg+ve  and  -ve 1.01E-04 4.57E-05–1.53E-04 1.21E-04 1.83E-05–2.27E-04  9.39E-05 1.87E-05–1.77E-04 
AH-E HBeAg+ve  1.94E-04 7.98E-06–3.75E-04 9.29E-04 1.81E-05–2.018E-03  6.97E-04 1.41E-04–1.28E-03 
AH-F HBeAg+ve  and  -ve 5.29E-04 3.49E-04–6.85E-04 1.11E-03 5.18E-04–1.76E-03  8.39E-04 4.44E-04–1.20E-03 
AH-H HBeAg+ve  4.39E-05 3.97E-08–1.11E-04 2.88E-04 6.48E-07–6.67E-04  1.75E-04 3.77E-06–3.54E-04 
WH-BC HBeAg-ve  9.55E-05  4.80E-05–1.52E-04 1.12E-04 1.40E-07–2.21E-04  9.63E-05  9.31E-06–1.80E-04 
WH-C  HBeAg+ve and -ve  1.15E-04  3.09E-05–2.13E-04 -   -  
WH-D HBeAg+ve  and  -ve 1.36E-04  9.40E-05–1.80E-04 1.17E-04 3.49E-05–2.08E-04  5.78E-05  1.08E-05–1.16E-04 
Table 3. Evolutionary rates estimated from four data sets restricted only to HBeAg+ve sequences. 
Data Set Antigen  state Strict  Clock  UCLD Relaxed Clock  UCLD Relaxed Clock 
   Mean  95% HPD  UCLD Mean  95% HPD Weighted  Mean  95%  HPD 
AH-C HBeAg+ve  8.76E-05 
1.48E-06–1.79E-
04 
2.47E-04 
1.20E-05–4.84E-04 2.29E-04 
1.15E-05–
4.37E-04 
AH-D HBeAg+ve  5.93E-05 
1.26E-04–1.01E-
04 
7.60E-05 
1.90E-05–1.43E-04 6.73E-05 
1.37E-05–
1.23E-04 
AH-F HBeAg+ve  1.80E-04 
4.78E-05–3.41E-
04 
5.61E-04 
2.06E-05–1.15E-03 4.10E-04 
3.22E-05–
7.62E-04 
WH-D HBeAg+ve  3.74E-05 
8.83E-06–7.11E-
05 
- 
   -    
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Table 4. Evolutionary rates estimated for the combined within-host and among-host data 
sets assuming a strict molecular clock and the shared-rate approach. 
   HBeAg-ve HBeAg+ve   
   Mean  95% HPD  Mean  95% HPD 
Within-host 1.10E-04  8.23E-05–1.41E-04  2.60E-05 1.49E-05–3.75E-05 
Among-host   2.01E-04  4.88E-05–3.32E-04  6.10E-05  1.97E-05–1.02E-04 
 
2.3. Variation in Evolutionary Rate within HBV Genomes  
To explore further the effect of e antigen status on evolutionary rate, we next partitioned the HBV 
genome into different regions, allowing each partitioned region to have its own evolutionary rate   
(the relative rate approach). Using the four data sets described above (data sets 4, 5, 14 and 15), we 
partitioned the genome in two ways. First, to test whether the structural composition of the genome 
influenced the evolutionary rate, we partitioned the genome into overlapping and non-overlapping 
regions. If overlapping regions are under stronger selective constraint than are non-overlapping 
regions, this analysis should result in a faster evolutionary rate for the non-overlapping partition 
regardless of the e-antigen status of the data set.  
Second, we allowed different rates for the CURS-Core region (nucleotides 1645 to 2454), and the 
remainder of the HBV genome. This partitioning strategy thus allows us to estimate separately the 
evolutionary rate for the region influencing HBeAg expression and the remainder of the HBV genome. 
The results of the partitioned analyses are presented in Tables 5 and 6. While we observe a trend 
suggesting that the overlapping region of the genome may evolve more slowly than the   
non-overlapping region, this trend is not significant (95% HPD intervals overlap for all four data sets). 
These results suggest that, while the existence of the overlapping reading frames remains an important 
consideration in HBV evolutionary models, standard analytical methods are sufficient to accommodate 
this rate variation and that excluding the overlapping regions is unnecessary.  
Table 5. Evolutionary rates for complete genomes, overlapping regions and non 
overlapping regions estimated from the combined genotype data sets. 
      Strict Clock  UCLD Relaxed Clock 
     Mean  95% HPD  UCLD Mean  95% HPD 
Within-host 
HBeAg +ve 
complete genome  2.60E-05  1.49E-05–3.75E-05 4.43E-05  2.24E-05–6.96E-05
nonoverlapping 3.30E-05  1.89E-05–4.83E-05 5.87E-05 2.94E-05–9.31E-05
overlapping 1.71E-05  9.38E-06–2.47E-05 3.07E-05  1.36E-05–4.4E-05 
Within-host 
HBeAg -ve 
complete genome  1.10E-04  8.23E-05–1.41E-04 1.17E-04  8.40E-05–1.53E-04
nonoverlapping 1.34E-04  9.59E-05–1.72E-04 1.42E-04 9.94E-05–1.88E-04
overlapping 8.66E-05  6.06E-05–1.41E-04 9.30E-05  6.41E-05–1.16E-04
Among-host 
HBeAg +ve 
complete genome  6.10E-05  1.97E-05–1.02E-04 6.20E-05  2.09E-05–1.06E-04
nonoverlapping 8.36E-05  3.64E-05–1.38E-04 8.26E-05 2.81E-05–1.41E-04
overlapping 4.29E-05  1.56E-05–6.77E-05 4.25E-05  1.52E-05–7.37E-05
Among-host 
HBeAg -ve 
complete genome  2.01E-04  4.88E-05–3.32E-04 1.89E-04  3.96E-05–3.44E-04
nonoverlapping 2.52E-04  8.74E-05–4.37E-04 2.34E-04 4.47E-05–4.24E-04
overlapping 1.56E-04  5.36E-05–2.71E-04 1.45E-04  3.01E-05–2.65E-04Viruses 2011, 3                  
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A more interesting pattern emerges from the comparison of the CURS-Core region and the rest of 
the genome (Table 6). For both HBeAg+ve data sets, we observe no difference in evolutionary rate 
between the CURS-Core region and the rest of the genome. However, faster evolutionary rates are 
estimated for the CURS-Core region compared to the remainder of the genome for both HBeAg-ve 
data sets. This pattern is most pronounced in the WH-HBeAg-ve data set, where there is a log factor 
difference in evolutionary rate between the two partitions. The WH analysis is a direct comparison of 
sequences before and after seroconversion (see the within-host supplementary information), suggesting 
that the viral evolutionary rate is strongly influenced by the immunological status of the host.  
Table 6. Evolutionary rates for complete genome, non CURS-Core region and CURS-Core 
region estimated from the combined genotype data sets. 
      Strict Clock  UCLD Relaxed Clock 
     Mean 95%  HPD  UCLD 
Mean  95% HPD 
Within-host 
HBeAg +ve 
complete genome  2.58E-05  1.53E-05–3.74E-05  4.77E-05  2.55E-05–7.94E-05
non CURS-Core  2.62E-05  1.52E-05–3.76E-05  4.81E-05  2.47E-05–7.95E-05
CURS-Core 2.49E-05  1.26E-05–3.68E-05  4.67E-05  2.06E-05–7.77E-05
Within-host 
HBeAg -ve 
complete genome  1.09E-04  8.13E-05–1.39E-04  1.24E-04  8.71E-05–1.62E-04
non CURS-Core  8.61E-05  6.35E-05–1.09E-04  9.72E-05  6.85E-05–1.31E-04
CURS-Core 1.79E-04  1.21E-04–2.35E-04  2.02E-04  1.37E-04–2.72E-04
Among-host 
HBeAg +ve 
complete genome  5.99E-05  2.32E-05–9.92E-05  6.31E-05  2.20E-05–1.00E-04
non CURS-Core  6.24E-05  2.27E-05–1.02E-04  6.58E-05  2.30E-05–1.05E-04
CURS-Core 5.23E-05  1.87E-05–8.66E-05    5.50E-05  2.01E-05–8.96E-05
Among-host 
HBeAg -ve 
complete genome  1.95E-04  1.89E-05–3.36E-04  2.00E-04  6.32E-05–3.42E-04
non CURS-Core  1.78E-04  2.34E-05–3.13E-04  1.83E-04  5.38E-05–3.08E-04
CURS-Core 2.44E-04  2.60E-05–4.29E-04    2.51E-04  6.91E-05–4.25E-04
 
Such localized rate variation is likely due to the immunological interactions of the HBeAg and the 
HBcAg (Hepatitis B virus core antigen). The HBeAg is a 29 amino acid (upstream) extension of 
HBcAg; both antigens express the same epitopes. In the early stages of chronic carriage, the HBeAg is 
expressed and stimulates regulatory T cells that suppress anti-viral T cell responses against the 
HBcAg, a key antigen expressed on the hepatocyte cell walls essential for virion formation [22,23]. 
HBeAg expression therefore assists in viral persistence, prevents excessive immunological damage to 
the liver, and minimizes host immune selection pressure on the HBcAg. However, in late chronic 
infection, hosts frequently develop antibodies to HBeAg (anti-HBeAg) whereupon the virus mutates, 
resulting in a HBeAg negative (HBeAg-ve) infection. When this occurs, translation and expression of 
the HBcAg, as well as the polymerase, is enhanced, leading to increased viral replication [26,33], and 
the regulation of the immune response is lifted. The combined result is a higher rate of replication and 
stronger immune selection pressure, which in turn will result in greater sequence variation. 
Consequently, under these conditions, the CURS-Core region is under strong selection pressure from 
the host immune system and mutations in the HBcAg can provide a selective advantage to the virus, 
enabling viral persistence.  Viruses 2011, 3                  
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2.3. Modeling the Influence of HBeAg Serological State on Evolutionary Rate  
Finally, we performed an additional series of analyses in which we directly assessed the   
influence of e antigen status on the evolutionary rate. We used several novel modifications of the delta 
model [42], which models additional substitutions along specific branches in a phylogeny. 
Specifically, we compare a specific delta, in which branches leading to HBeAg-ve leaves are allowed 
to evolve more rapidly than the other branches in the tree, a general delta, in which all terminal 
branches are allowed to evolve more quickly than internal branches (this accommodates extra 
substitutions that may be present in each branch, for example as may occur while weakly deleterious 
mutations are in the process of being removed from the population), and a no delta, in which all 
branches evolve at the same rate. Delta analyses were performed on the three genotype-specific data 
sets for which sufficient numbers of both HBeAg+ve and HBeAg-ve sequences were available   
(WH-D, AH-C and AH-D; data sets 2, 9 and 10). 
Results of the delta model analyses are presented in Table 7. For the AH-D and WH-D data sets, 
Bayes factors indicate strong support favoring the specific delta model over the general delta model 
(AH-D 2lnB01 = 33.56; WH-D 2lnB01 = 68) and the specific delta model over the no delta model 
(AH-D 2lnB01 = 22.30; WH-D 2lnB01 = 66). There is also marginal support (AH-D 2lnB01 = 11.2; 
WH-D 2lnB01 = 2.44) for the no delta model over the general delta model. These results suggest an 
increased rate of substitution only along terminal branches leading to HBeAg-ve sequences. When 
these excess substitutions are accommodated by the specific delta model the global evolutionary rate 
slows to a value comparable to that estimated for the AH-D data set without HBeAg-ve sequences. 
The specific delta parameter therefore appears to have absorbed the rate difference observed between 
HBeAg-ve and HBeAg+ve sequences enabling a more accurate estimation of the long-term 
evolutionary rate.  
Table 7. Evolutionary rate estimates under the no delta, specific delta and general delta 
models rate for the WH-D, AH-D and AH-C data sets. 
Datasets Model  Clock 
Rate 
95% HPD  Delta 
Distribution
95% HPD  Log P 
WH- D 
No delta  1.36E-04  9.40E-05–1.80E-04  -  -  -6319.237 
General Delta  1.31E-04  8.52E-05–1.74E-04  skewed to zero -  -6320.459 
Specific Delta  4.35E-05  1.26E-05–7.41E-05  5.62E-03  4.09E-03–6.94E-03  -6286.171 
AH- D 
No delta  1.02E-04  4.57E-05–1.53E-04  -  -  -10732.539 
General Delta  9.58E-05  4.30E-05–1.50E-04 5.16E-04  1.65E-04–9.26E-04  -10738.168 
Specific Delta  6.74E-05  1.56E-05–1.14E-04  2.54E-03  1.77E-03- 3.24E-03  -10721.39 
AH- C 
No delta  1.20E-04  2.98E-05–1.95E-04    -  -19005.325 
General Delta  8.48E-05  2.07E-05–1.54E-04 1.66E-03  8.07E-04–2.44E-03  -19007.966 
Specific Delta  8.45E-05  2.29E-05–1.56E-04  1.90E-03  7.40E-04–3.11E-03  -19005.66 
 
For the AH-C dataset, we find only moderate support favoring the specific delta over the general 
delta (2lnB01 = 4.6) and no support for favoring the specific delta over the model without delta 
(2lnB01 = −0.67). This difference between the genotype D and genotype C may be due to their 
different susceptibility to CURS BCP and preCore mutations. We defined HBeAg-ve status by 
serological test results and the presence of the G1896A mutation. However, mutations in the CURS Viruses 2011, 3                  
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and BCP region can reduce HBe antigen expression, resulting in a similar immunological and 
virological state to HBeAg-ve serological status. The genomic sequence and structure of genotype C is 
less susceptible to the G1896A mutation and more susceptible to CURS and BCP mutations than is 
genotype D [43], which may explain the results observed here. 
3. Conclusions 
In this work, we use several different Bayesian inference models to estimate the evolutionary rate 
from a broad geographic sample of HBV complete genomes. We compare differences in evolutionary 
rate between genotypes, between regions of the genome, and between viruses with different 
serological states. We found that regardless of genotype, a change in serological state from HBeAg+ve 
to HBeAg-ve coincides with an increase in evolutionary rate. In addition, we found that neither 
genotype nor genomic region significantly influences the estimated rate in our sample of HBV. We 
also note that in comparing WH and AH data sets, inference was often more straightforward for data 
sets where the viral strains were most closely related (WH). Given that AH data sets will have 
significantly more variables that the models will need to accommodate, this result is perhaps 
unsurprising. Nonetheless, this result highlights the significant evolutionary variation that is known to 
exist both within and between viral data sets, clearly demonstrating how this variation can confound 
phylogenetic and phylogeographic analyses. 
Differences between HBeAg positive and negative serological states have been recognized at both 
the clinical and nucleotide sequence level for some time. For example, it is known that the clinical 
prognosis for HBeAg-ve individuals with low viral titer is far better than for HBeAg+ve individuals 
with high viral titer [41] and it is has been reported that sequence divergence, as a whole, is greater in 
HBeAg-ve sequences [18]. Our results illustrate that including HBeAg-ve sequences in phylogenetic 
analysis of individual genotypes is likely to bias evolutionary rate estimates, and that these biases can 
be inconsistent between genotypes. We therefore recommend that future analyses of the global 
distribution of HBV genotypes are careful to appropriately model HBeAg status. 
4. Methods 
4.1. Data Collection 
Pacific Island HBV positive samples were either provided by persons as listed in the 
acknowledgements or were identified from a tri-nation screening program involving Papua New 
Guinea, Fiji and Kiribati to investigate HBV vaccine escape, viral diversity, and phylogeography in 
South Pacific island countries. Ethical permission was obtained from each country through the 
appropriate committees. Viral DNA was extracted from serum samples using the High Pure Viral 
Nucleic Acid
TM Kit—for the isolation of nucleic acids for PCR or RT-PCR, as per manufacturers’ 
instructions. Complete HBV genomes were PCR-amplified in two overlapping fragments as described 
by Gunther et al. [30] using primers HB1839R (GCTTGAGCTCTTCAAAAAGTTGCATGGTGCTGG)-
HB1877F (GCTTGAGCTCTTCTTTTTCACCTCTGCCTAATCA) for the complete genome, and 
HB1611 (CGCTTCACCTCTGCACGTCGCA)-HB2313 (YTCCGGAAGTGTTGATARGATAGG) 
for the smaller overlap. Roche Expand High Fidelity PCR-plus™ enzyme was used as per the kit Viruses 2011, 3                  
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recommendations. The genomic PCR DNA fragments were either sequenced directly or used as 
template in a second-round nested PCR to generate shorter fragments (0.8–1.6 kb). The times and 
temperatures for the extension and primer annealing steps varied slightly depending on the expected 
length of the fragment and the desired annealing temperature of the primers, respectively. In total, 112 
complete HBV genomes with known sampling date were sequenced using this approach (GenBank 
accession numbers HQ700439-HQ700440, HQ700442-HQ700443, HQ700445-HQ700448, 
HQ700452, HQ700454-HQ700456, HQ700458-HQ700459, HQ700461-HQ700462, HQ700464, 
HQ700466-HQ700470, HQ700472-HQ700474, HQ700477-HQ700478, HQ700480-HQ700481, 
HQ700484-HQ700486, HQ700488-HQ700490, HQ700492-HQ700527, HQ700530-HQ700541). 
To construct expanded global data sets, we obtained an additional 228 sequences representing all 
information-complete HBV genomes available in Genbank as of April 2007. Sequences were regarded 
as information-complete when data for collection dates, serological status (HBeAg and   
anti-HBeAg), and epidemiological relationships between samples could be compiled, either via direct 
communication with the authors or from the relevant publications. An additional 85 sequences were 
obtained in July 2010 to increase the number of sequences for the HBV genotypes A, E, F, and H to 
greater than, or equal to, 20 each. (A detailed description of each genome sequence is provided as 
Supplementary Material Table 1).  
The complete data set of 425 HBV genomes was subdivided into two major categories. The first 
group of data sets includes longitudinal samples collected from within individual hosts and short-term 
transmission (pedigree) data (WH data sets). We compiled four WH data sets: recombinant genotype 
BC (WH-BC; [16]), genotype C (WH-C; this study), genotype D (WH-D; [15,16], this study), and a 
combined pedigree dataset from three epidemiologically unlinked families (WH-Fa; [44]). To 
investigate the effect of HBeAg status on the evolutionary rate of HBV and to investigate rate 
variation between different regions of the genome, sequences from all four WH data sets were pooled 
and used to construct separate WH-HBeAg-ve and WH-HBeAg+ve data sets. Second, to address 
among-host evolution, we compiled data sets comprising epidemiologically unrelated genomes   
(AH data sets). Based on the number of genomes available, we were able to compile six   
genotype-specific AH data sets: genotypes A, C, D, E, F and H. As above, the AH sequences were 
then pooled and used to compile AH-HBeAg+ve and AH-HBeAg-ve data sets for further   
analysis (Table 1).  
4.2. Detecting Recombinants 
To detect inter-genotype recombinant HBV genomes, we used a modified version of the Oxford 
Hepatitis B Virus Genotyping Tool that included representative simian HBV strains. This tool is 
available on the BioAfrica web site [45]. Within-genotype recombination was assessed initially using 
the Phi-test, which uses the pairwise homoplasy index to assess whether the substitution patterns 
deviate significantly from clonality [46,47]. If this test revealed significant evidence for 
recombination, the program 3SEQ was used to identify putative recombinants [47]. In the case where 
these two intra-genotype methods were inconsistent, we also investigated reticulate evolution using 
SplitsTree, [48]. The recombinants identified using this approach are listed in the supplementary Viruses 2011, 3                  
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material (Supplementary Table 2). All putative recombinants except the pedigree genotype rBC 
sequences (WH-BC) were excluded from further analysis.  
4.3. Inferring Evolutionary Rates 
Evolutionary rates were estimated using Bayesian Monte Carlo Markov Chain (MCMC) analyses 
as implemented in BEAST [31] using the Hasegawa-Kishino-Yano model of evolution (HKY85) with 
a proportion of invariant sites, and a constant population size demographic model [49]. For the WH-Fa 
data set, the time to the most recent common ancestor (MRCA) for each child lineage and any other 
lineage was constrained to be earlier than the date of birth of the child. In addition, the root of the 
complete familial genealogies was constrained to be younger than the date of birth of the mother. In 
essence, this represents a full probabilistic genealogical estimation procedure for a previously reported 
pedigree rate estimation problem [50].  
For all data sets, both strict and relaxed (uncorrelated lognormal distribution; [32]) clocks were 
applied in separate analyses. MCMC chains were run until stationarity was achieved, as evaluated 
using Tracer [51]. Rate variation between specific genomic regions was modeled using relative rate 
parameters. Novel models developed for this analysis are presented below. Trees were summarized 
using TreeAnnotator and visualized in FigTree [52]. 
4.4. BEAST Analyses 
BEAST [31] is a flexible, coalescent-based platform for phylogenetic and genealogic inference. In 
addition to more standard coalescent models described above, we take advantage of this flexibility to 
test the hypotheses evaluated above using three additional models.  
4.4.1. Shared-rate Approach 
The WH-BC and WH-Fa datasets include inter-genotype recombinant B-C sequences. Since the 
shared ancestry of non-recombinant and recombinant lineages cannot be modeled with a strictly 
bifurcating tree, we allow each within-host data set and each family to act as a ‘subpopulation’ and 
have its own genealogy, while sharing the rate across the genealogies. This shared-rate approach was 
used for all analyses of the WH-BC and WH-Fa data sets, as well as for the analyses of the larger 
HBeAg+ve and HBeAg-ve data sets, where separate genealogies were estimated for each of the 
genotypes within the larger data set. 
This approach shares the substitution rate, the transition/transversion ratio and the proportion of 
invariant sites across the individual genealogies, although the genealogies are allowed to be different 
for each subset of sequences. Under the relaxed clock model, for each separate genealogy   
branch-specific rates are sampled from underlying lognormal distributions with the same mean but 
different standard deviations. This approach is conceptually similar to the likelihood-based approaches 
developed by Rodrigo et al. [5,53]; the Bayesian model implementation is, however, similar to the 
‘unlinked model’ of Lemey et al. [53].  Viruses 2011, 3                  
 
97
4.4.2. Relative Rates Approach  
To investigate rate variability across the genome, we incorporated relative rates across different 
alignment partitions. This approach uses a relative rate factor, rj, for m different genome regions, In 
combination with the shared-rate approach, rj is the same for the same genome region in all the n 
subpopulations. Using this model, we evaluated the relative rate differences between overlapping and 
non-overlapping genome regions, as well as between the CURS, BCP preCore and the Core regions 
(1645–2454 nt) and the rest of the HBV genome. 
4.4.3. Specific Delta Model 
We hypothesize that the change in antigen state from HBeAg+ve to HBeAg-ve can result in a 
change in the evolutionary rate. To test this, we implement a model that allows a subset of lineages to 
evolve at a different rate compared to the rest of the tree.  
Ho et al. [42] provide a Bayesian model that allowed an extra amount of substitutions to occur 
along terminal branches. This model, referred to as the delta model, was used to estimate and 
accommodate DNA damage in ancient DNA sequences. We extend the delta model to allow extra 
substitutions to occur along specified terminal branches in the tree, applied here to HBeAg-ve 
sequences. The fit of this model (‘specific delta’) was compared to the fit of a model that allowed the 
same additional amount of substitutions for all tips (‘general delta’) and a model that did not allow for 
additional substitutions at the tips (‘no delta’). Models were compared using Bayes factors 
(specifically, two times the log of the Bayes factor, 2lnB01, where B01 = P(Model 0|Data)/ P(Model 
1|Data)) [54]. Comparisons were performed on the three data sets that had sufficient HBeAg-ve and 
HBeAg+ve sequences (WH-D, AH-D and AH-C datasets). 
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